PE0139
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PE0139, covering 2014-10-15 to 2018-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM [Phase 2]